

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sensory perception of smell (GO:0007608) | 6.96435721 |
| 2 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.52446213 |
| 3 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 5.17080841 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.16938471 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 5.08080027 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.88888104 |
| 7 | glutamate secretion (GO:0014047) | 4.83528267 |
| 8 | synaptic vesicle maturation (GO:0016188) | 4.73757715 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.66246756 |
| 10 | sensory perception of chemical stimulus (GO:0007606) | 4.64932866 |
| 11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.61840599 |
| 12 | negative regulation of T cell mediated immunity (GO:0002710) | 4.58732098 |
| 13 | synaptic vesicle exocytosis (GO:0016079) | 4.57696472 |
| 14 | vocalization behavior (GO:0071625) | 4.54891805 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.43023174 |
| 16 | phosphorelay signal transduction system (GO:0000160) | 4.39591646 |
| 17 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.36550897 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 4.33971686 |
| 19 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.33903223 |
| 20 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.30154968 |
| 21 | interferon-gamma production (GO:0032609) | 4.23407809 |
| 22 | regulation of synapse structural plasticity (GO:0051823) | 4.21023122 |
| 23 | neurotransmitter secretion (GO:0007269) | 4.19074562 |
| 24 | histone H3-K36 demethylation (GO:0070544) | 4.13088074 |
| 25 | regulation of chromatin binding (GO:0035561) | 4.11035018 |
| 26 | locomotory exploration behavior (GO:0035641) | 4.10033115 |
| 27 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.04237680 |
| 28 | regulation of synaptic vesicle transport (GO:1902803) | 3.99740222 |
| 29 | protein localization to cilium (GO:0061512) | 3.98555485 |
| 30 | mating behavior (GO:0007617) | 3.98344444 |
| 31 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.93379264 |
| 32 | behavioral response to cocaine (GO:0048148) | 3.85608651 |
| 33 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.80543525 |
| 34 | protein localization to synapse (GO:0035418) | 3.74402978 |
| 35 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.73127774 |
| 36 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.65843171 |
| 37 | histone H3-K4 trimethylation (GO:0080182) | 3.65612630 |
| 38 | axonal fasciculation (GO:0007413) | 3.64842670 |
| 39 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.63597986 |
| 40 | layer formation in cerebral cortex (GO:0021819) | 3.61752810 |
| 41 | gamma-aminobutyric acid transport (GO:0015812) | 3.61346679 |
| 42 | membrane depolarization during action potential (GO:0086010) | 3.57667961 |
| 43 | neuron recognition (GO:0008038) | 3.56579237 |
| 44 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.54344913 |
| 45 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.52644124 |
| 46 | calcium ion-dependent exocytosis (GO:0017156) | 3.52441906 |
| 47 | negative regulation of microtubule polymerization (GO:0031115) | 3.49720228 |
| 48 | protein insertion into membrane (GO:0051205) | 3.48542185 |
| 49 | cellular response to ethanol (GO:0071361) | 3.46795608 |
| 50 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.45028291 |
| 51 | synaptic vesicle endocytosis (GO:0048488) | 3.44251138 |
| 52 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.42078766 |
| 53 | negative regulation of cell killing (GO:0031342) | 3.42078766 |
| 54 | detection of calcium ion (GO:0005513) | 3.40526730 |
| 55 | positive regulation of granulocyte differentiation (GO:0030854) | 3.39761484 |
| 56 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.38397944 |
| 57 | neurotransmitter transport (GO:0006836) | 3.34545473 |
| 58 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.33185681 |
| 59 | synaptic transmission, glutamatergic (GO:0035249) | 3.31423189 |
| 60 | regulation of histone H3-K27 methylation (GO:0061085) | 3.30772761 |
| 61 | protein polyglutamylation (GO:0018095) | 3.29202336 |
| 62 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.28708600 |
| 63 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.28332571 |
| 64 | activation of protein kinase A activity (GO:0034199) | 3.28295488 |
| 65 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.27325202 |
| 66 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.26916689 |
| 67 | proline transport (GO:0015824) | 3.26666983 |
| 68 | snRNA transcription (GO:0009301) | 3.25969247 |
| 69 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.21373766 |
| 70 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.21108734 |
| 71 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.20927157 |
| 72 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.20467177 |
| 73 | dopamine receptor signaling pathway (GO:0007212) | 3.20400143 |
| 74 | regulation of protein kinase A signaling (GO:0010738) | 3.19768796 |
| 75 | response to auditory stimulus (GO:0010996) | 3.18726647 |
| 76 | glutamate receptor signaling pathway (GO:0007215) | 3.18460698 |
| 77 | neuron-neuron synaptic transmission (GO:0007270) | 3.17647799 |
| 78 | cellular potassium ion homeostasis (GO:0030007) | 3.16688867 |
| 79 | B cell receptor signaling pathway (GO:0050853) | 3.16497326 |
| 80 | long-term memory (GO:0007616) | 3.14563630 |
| 81 | exploration behavior (GO:0035640) | 3.13623364 |
| 82 | positive regulation of synapse maturation (GO:0090129) | 3.13263593 |
| 83 | vesicle transport along microtubule (GO:0047496) | 3.12973519 |
| 84 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.12240508 |
| 85 | regulation of neurotransmitter secretion (GO:0046928) | 3.10852287 |
| 86 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.09144920 |
| 87 | positive regulation of neurotransmitter transport (GO:0051590) | 3.08204860 |
| 88 | response to interleukin-15 (GO:0070672) | 3.06741200 |
| 89 | dendrite morphogenesis (GO:0048813) | 3.06587591 |
| 90 | mannose metabolic process (GO:0006013) | 3.05778102 |
| 91 | regulation of female receptivity (GO:0045924) | 3.05294624 |
| 92 | regulation of cilium movement (GO:0003352) | 3.04898438 |
| 93 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.04134097 |
| 94 | histone H3-K9 demethylation (GO:0033169) | 3.03743565 |
| 95 | regulation of neurotransmitter levels (GO:0001505) | 3.03419826 |
| 96 | regulation of synaptic plasticity (GO:0048167) | 3.02640073 |
| 97 | positive regulation of histone deacetylation (GO:0031065) | 3.02415148 |
| 98 | neuronal action potential propagation (GO:0019227) | 3.00515074 |
| 99 | neuronal action potential (GO:0019228) | 2.99589233 |
| 100 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.98025104 |
| 101 | neuromuscular process controlling posture (GO:0050884) | 2.97961269 |
| 102 | brain morphogenesis (GO:0048854) | 2.97819085 |
| 103 | prepulse inhibition (GO:0060134) | 2.97520577 |
| 104 | drug catabolic process (GO:0042737) | 2.97167012 |
| 105 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.97054819 |
| 106 | exogenous drug catabolic process (GO:0042738) | 2.97032924 |
| 107 | auditory behavior (GO:0031223) | 2.95504489 |
| 108 | establishment of protein localization to Golgi (GO:0072600) | 2.95202097 |
| 109 | cellular response to glucagon stimulus (GO:0071377) | 2.94913512 |
| 110 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.94686887 |
| 111 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.94106010 |
| 112 | activated T cell proliferation (GO:0050798) | 2.93644630 |
| 113 | cellular response to prostaglandin stimulus (GO:0071379) | 2.93255661 |
| 114 | positive regulation of membrane potential (GO:0045838) | 2.93022936 |
| 115 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.92015168 |
| 116 | membrane hyperpolarization (GO:0060081) | 2.90121421 |
| 117 | regulation of postsynaptic membrane potential (GO:0060078) | 2.90004129 |
| 118 | female mating behavior (GO:0060180) | 2.87972736 |
| 119 | negative thymic T cell selection (GO:0045060) | 2.87921081 |
| 120 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.87674194 |
| 121 | synapse assembly (GO:0007416) | 2.86747902 |
| 122 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.86479339 |
| 123 | positive regulation of T cell cytokine production (GO:0002726) | 2.86274432 |
| 124 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.85539931 |
| 125 | negative regulation of adaptive immune response (GO:0002820) | 2.84976171 |
| 126 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.84911927 |
| 127 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.84425168 |
| 128 | positive regulation of type 2 immune response (GO:0002830) | 2.84316641 |
| 129 | regulation of ARF protein signal transduction (GO:0032012) | 2.84285174 |
| 130 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.84232381 |
| 131 | postsynaptic membrane organization (GO:0001941) | 2.83533429 |
| 132 | dendritic spine morphogenesis (GO:0060997) | 2.83287001 |
| 133 | intraciliary transport (GO:0042073) | 2.82916568 |
| 134 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.82831061 |
| 135 | regulation of neurotransmitter transport (GO:0051588) | 2.81566352 |
| 136 | negative T cell selection (GO:0043383) | 2.80775876 |
| 137 | organelle transport along microtubule (GO:0072384) | 2.80647119 |
| 138 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.80263358 |
| 139 | transmission of nerve impulse (GO:0019226) | 2.80151156 |
| 140 | membrane depolarization (GO:0051899) | 2.79301246 |
| 141 | long-term synaptic potentiation (GO:0060291) | 2.78932434 |
| 142 | cardiac conduction (GO:0061337) | 2.78888116 |
| 143 | positive regulation of Rap GTPase activity (GO:0032854) | 2.77821988 |
| 144 | cellular extravasation (GO:0045123) | 2.77166165 |
| 145 | synaptic transmission (GO:0007268) | 2.75892782 |
| 146 | cell migration in hindbrain (GO:0021535) | 2.74754610 |
| 147 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.74492597 |
| 148 | positive thymic T cell selection (GO:0045059) | 2.70356490 |
| 149 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.69076875 |
| 150 | regulation of granulocyte differentiation (GO:0030852) | 2.66224172 |
| 151 | protein targeting to Golgi (GO:0000042) | 2.66104123 |
| 152 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.65321383 |
| 153 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.63567616 |
| 154 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.63061435 |
| 155 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.58475606 |
| 156 | histone lysine demethylation (GO:0070076) | 2.57734237 |
| 157 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.56675664 |
| 158 | positive T cell selection (GO:0043368) | 2.55955377 |
| 159 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.55519050 |
| 160 | histone H3-K4 methylation (GO:0051568) | 2.55485769 |
| 161 | interkinetic nuclear migration (GO:0022027) | 2.53308830 |
| 162 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.52051315 |
| 163 | positive regulation of protein deacetylation (GO:0090312) | 2.51570642 |
| 164 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.51378973 |
| 165 | negative regulation of B cell mediated immunity (GO:0002713) | 2.51378973 |
| 166 | T cell selection (GO:0045058) | 2.47332365 |
| 167 | growth hormone receptor signaling pathway (GO:0060396) | 2.47315209 |
| 168 | regulation of T cell cytokine production (GO:0002724) | 2.46828194 |
| 169 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.45714435 |
| 170 | regulation of ARF GTPase activity (GO:0032312) | 2.45574912 |
| 171 | regulation of Rab GTPase activity (GO:0032313) | 2.45553085 |
| 172 | positive regulation of Rab GTPase activity (GO:0032851) | 2.45553085 |
| 173 | thymic T cell selection (GO:0045061) | 2.45432658 |
| 174 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.43803256 |
| 175 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.42631848 |
| 176 | cellular response to interleukin-15 (GO:0071350) | 2.41820729 |
| 177 | histone H3-K9 modification (GO:0061647) | 2.41526085 |
| 178 | histone demethylation (GO:0016577) | 2.41509859 |
| 179 | positive regulation of B cell differentiation (GO:0045579) | 2.40055978 |
| 180 | epoxygenase P450 pathway (GO:0019373) | 2.39874017 |
| 181 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.39257372 |
| 182 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.39257372 |
| 183 | modulation by symbiont of host immune response (GO:0052553) | 2.39257372 |
| 184 | positive regulation by symbiont of host defense response (GO:0052509) | 2.39257372 |
| 185 | modulation by symbiont of host defense response (GO:0052031) | 2.39257372 |
| 186 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.39257372 |
| 187 | germinal center formation (GO:0002467) | 2.38740561 |
| 188 | regulation of protein activation cascade (GO:2000257) | 2.38095717 |
| 189 | regulation of complement activation (GO:0030449) | 2.37890002 |
| 190 | leukocyte aggregation (GO:0070486) | 2.36241052 |
| 191 | lymphocyte chemotaxis (GO:0048247) | 2.36076218 |
| 192 | histone lysine methylation (GO:0034968) | 2.35970330 |
| 193 | regulation of B cell mediated immunity (GO:0002712) | 2.35509269 |
| 194 | detection of bacterium (GO:0016045) | 2.35335380 |
| 195 | complement activation, alternative pathway (GO:0006957) | 2.34557951 |
| 196 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.33449577 |
| 197 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.32154969 |
| 198 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.31196715 |
| 199 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.30796333 |
| 200 | detection of other organism (GO:0098543) | 2.30674349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 7.40967344 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.18301632 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.38648336 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.37934567 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.10525927 |
| 6 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.66845879 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.65583920 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.64808313 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.55509724 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.48535811 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.46908365 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.46908365 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.46637863 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.42367559 |
| 15 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.30612662 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.25918481 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.18962506 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.16373105 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.15961491 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.14622237 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.10816656 |
| 22 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.05066224 |
| 23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.04176147 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.01840742 |
| 25 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.01429160 |
| 26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.00049222 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.97819019 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.97636688 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.93782400 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.90181237 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.87781383 |
| 32 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.87476887 |
| 33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.87332459 |
| 34 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.75097618 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.70245887 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.67886777 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.67409449 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.66377354 |
| 39 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.65066429 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.64186836 |
| 41 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.63495549 |
| 42 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.61778542 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.59971499 |
| 44 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.59561069 |
| 45 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.58412000 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52975421 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.51483644 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51160106 |
| 49 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.50502760 |
| 50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.50239098 |
| 51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50134045 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.50050722 |
| 53 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.49678489 |
| 54 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49647946 |
| 55 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48789732 |
| 56 | GATA1_19941826_ChIP-Seq_K562_Human | 1.46125052 |
| 57 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.45061892 |
| 58 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.43389980 |
| 59 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.43249107 |
| 60 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.43131446 |
| 61 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42865233 |
| 62 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.42668787 |
| 63 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.41952551 |
| 64 | MYB_26560356_Chip-Seq_TH2_Human | 1.41650484 |
| 65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.39521750 |
| 66 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.38096668 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37361837 |
| 68 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.36664385 |
| 69 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.34917860 |
| 70 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.34717433 |
| 71 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.34637056 |
| 72 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.33893558 |
| 73 | P300_19829295_ChIP-Seq_ESCs_Human | 1.33262846 |
| 74 | MAF_26560356_Chip-Seq_TH1_Human | 1.31536272 |
| 75 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.31386767 |
| 76 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.29522720 |
| 77 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28535624 |
| 78 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.27159840 |
| 79 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26923946 |
| 80 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26777615 |
| 81 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26713546 |
| 82 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25000937 |
| 83 | GATA2_19941826_ChIP-Seq_K562_Human | 1.24328669 |
| 84 | STAT3_23295773_ChIP-Seq_U87_Human | 1.23193801 |
| 85 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22886639 |
| 86 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22814812 |
| 87 | MYB_26560356_Chip-Seq_TH1_Human | 1.22665214 |
| 88 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.21584190 |
| 89 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21090415 |
| 90 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.20989495 |
| 91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20871680 |
| 92 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.20491980 |
| 93 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.20331795 |
| 94 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.20079071 |
| 95 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.19636690 |
| 96 | MAF_26560356_Chip-Seq_TH2_Human | 1.19609845 |
| 97 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.19462853 |
| 98 | AR_19668381_ChIP-Seq_PC3_Human | 1.19354624 |
| 99 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19340536 |
| 100 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19161157 |
| 101 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19141258 |
| 102 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17745591 |
| 103 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17608116 |
| 104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17393192 |
| 105 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17282275 |
| 106 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17163157 |
| 107 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16183255 |
| 108 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15945273 |
| 109 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15841784 |
| 110 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.14248393 |
| 111 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13535965 |
| 112 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.13507904 |
| 113 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12427595 |
| 114 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.12427595 |
| 115 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12292957 |
| 116 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.11699949 |
| 117 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.11658028 |
| 118 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11194727 |
| 119 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11160353 |
| 120 | P68_20966046_ChIP-Seq_HELA_Human | 1.09951235 |
| 121 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09808485 |
| 122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08014949 |
| 123 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.07779652 |
| 124 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.06368462 |
| 125 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05818431 |
| 126 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02654219 |
| 127 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.02410844 |
| 128 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01463500 |
| 129 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01049811 |
| 130 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00876074 |
| 131 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00530979 |
| 132 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00141098 |
| 133 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98105075 |
| 134 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97807854 |
| 135 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97470784 |
| 136 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97166791 |
| 137 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96842308 |
| 138 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96280777 |
| 139 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.95965357 |
| 140 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95874463 |
| 141 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.94674116 |
| 142 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.94537845 |
| 143 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.93733247 |
| 144 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93397346 |
| 145 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92766203 |
| 146 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92694281 |
| 147 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91949505 |
| 148 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.91940585 |
| 149 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91715512 |
| 150 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91674681 |
| 151 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90815128 |
| 152 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.90596601 |
| 153 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90462499 |
| 154 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.89756676 |
| 155 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89493524 |
| 156 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.89489017 |
| 157 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.88874788 |
| 158 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.88430021 |
| 159 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.87793820 |
| 160 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.87554149 |
| 161 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.87498536 |
| 162 | * P300_27268052_Chip-Seq_Bcells_Human | 0.87357874 |
| 163 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.86962017 |
| 164 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85860414 |
| 165 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.85790021 |
| 166 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.85681399 |
| 167 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.85576318 |
| 168 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.85406447 |
| 169 | TP53_16413492_ChIP-PET_HCT116_Human | 0.85135768 |
| 170 | ERA_21632823_ChIP-Seq_H3396_Human | 0.85026367 |
| 171 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84181965 |
| 172 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84124476 |
| 173 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.84121027 |
| 174 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83920528 |
| 175 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83806698 |
| 176 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.83691530 |
| 177 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.83580156 |
| 178 | JUN_21703547_ChIP-Seq_K562_Human | 0.83440278 |
| 179 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.83376794 |
| 180 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.83087408 |
| 181 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.82580099 |
| 182 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.82563472 |
| 183 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.82215749 |
| 184 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.81372665 |
| 185 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.80319854 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001984_abnormal_olfaction | 5.72043220 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.79891039 |
| 3 | MP0005394_taste/olfaction_phenotype | 3.73218029 |
| 4 | MP0005499_abnormal_olfactory_system | 3.73218029 |
| 5 | MP0005645_abnormal_hypothalamus_physiol | 3.58655665 |
| 6 | MP0004270_analgesia | 3.52663224 |
| 7 | MP0008789_abnormal_olfactory_epithelium | 3.47409507 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 3.41260612 |
| 9 | MP0003880_abnormal_central_pattern | 3.31305451 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.85387765 |
| 11 | MP0003787_abnormal_imprinting | 2.80223383 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.73346944 |
| 13 | MP0009745_abnormal_behavioral_response | 2.69241507 |
| 14 | MP0003763_abnormal_thymus_physiology | 2.67328938 |
| 15 | MP0009046_muscle_twitch | 2.63929408 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.55211707 |
| 17 | MP0002064_seizures | 2.54948200 |
| 18 | MP0005310_abnormal_salivary_gland | 2.48418744 |
| 19 | MP0005360_urolithiasis | 2.46142357 |
| 20 | MP0003436_decreased_susceptibility_to | 2.41651830 |
| 21 | MP0002272_abnormal_nervous_system | 2.41046622 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 2.40433505 |
| 23 | MP0001486_abnormal_startle_reflex | 2.39519986 |
| 24 | MP0005423_abnormal_somatic_nervous | 2.38303034 |
| 25 | MP0001800_abnormal_humoral_immune | 2.38113387 |
| 26 | MP0003195_calcinosis | 2.37855729 |
| 27 | MP0002184_abnormal_innervation | 2.32689182 |
| 28 | MP0002572_abnormal_emotion/affect_behav | 2.30167525 |
| 29 | MP0001835_abnormal_antigen_presentation | 2.28456466 |
| 30 | MP0005365_abnormal_bile_salt | 2.27263727 |
| 31 | MP0006276_abnormal_autonomic_nervous | 2.25343801 |
| 32 | MP0000685_abnormal_immune_system | 2.19026605 |
| 33 | MP0001968_abnormal_touch/_nociception | 2.15900682 |
| 34 | MP0005646_abnormal_pituitary_gland | 2.12566340 |
| 35 | MP0001790_abnormal_immune_system | 2.10665993 |
| 36 | MP0005387_immune_system_phenotype | 2.10665993 |
| 37 | MP0003045_fibrosis | 2.07917107 |
| 38 | MP0002396_abnormal_hematopoietic_system | 2.03551140 |
| 39 | MP0002557_abnormal_social/conspecific_i | 1.96770417 |
| 40 | MP0002822_catalepsy | 1.95364116 |
| 41 | MP0003646_muscle_fatigue | 1.94431797 |
| 42 | MP0004130_abnormal_muscle_cell | 1.92666575 |
| 43 | MP0005670_abnormal_white_adipose | 1.92372418 |
| 44 | MP0005085_abnormal_gallbladder_physiolo | 1.86504269 |
| 45 | MP0001873_stomach_inflammation | 1.83898629 |
| 46 | MP0010329_abnormal_lipoprotein_level | 1.83477841 |
| 47 | MP0000778_abnormal_nervous_system | 1.82912893 |
| 48 | MP0002067_abnormal_sensory_capabilities | 1.82693114 |
| 49 | MP0001501_abnormal_sleep_pattern | 1.79592484 |
| 50 | MP0002723_abnormal_immune_serum | 1.77140154 |
| 51 | MP0004858_abnormal_nervous_system | 1.75483170 |
| 52 | MP0001485_abnormal_pinna_reflex | 1.73427013 |
| 53 | MP0005451_abnormal_body_composition | 1.69737853 |
| 54 | MP0005671_abnormal_response_to | 1.65375696 |
| 55 | MP0005000_abnormal_immune_tolerance | 1.63206723 |
| 56 | MP0002139_abnormal_hepatobiliary_system | 1.61568040 |
| 57 | MP0002419_abnormal_innate_immunity | 1.60636368 |
| 58 | MP0002735_abnormal_chemical_nociception | 1.60512673 |
| 59 | MP0002420_abnormal_adaptive_immunity | 1.60505326 |
| 60 | MP0008057_abnormal_DNA_replication | 1.58340641 |
| 61 | MP0005025_abnormal_response_to | 1.58205761 |
| 62 | MP0001819_abnormal_immune_cell | 1.56650373 |
| 63 | MP0002736_abnormal_nociception_after | 1.56068999 |
| 64 | MP0004811_abnormal_neuron_physiology | 1.55030505 |
| 65 | MP0004381_abnormal_hair_follicle | 1.54989934 |
| 66 | MP0002452_abnormal_antigen_presenting | 1.54534340 |
| 67 | MP0002882_abnormal_neuron_morphology | 1.54087583 |
| 68 | MP0003183_abnormal_peptide_metabolism | 1.52921000 |
| 69 | MP0002132_abnormal_respiratory_system | 1.50612930 |
| 70 | MP0002398_abnormal_bone_marrow | 1.48114670 |
| 71 | MP0009115_abnormal_fat_cell | 1.46185938 |
| 72 | MP0001970_abnormal_pain_threshold | 1.44378873 |
| 73 | MP0001986_abnormal_taste_sensitivity | 1.44372141 |
| 74 | MP0002160_abnormal_reproductive_system | 1.43159024 |
| 75 | MP0002006_tumorigenesis | 1.42811239 |
| 76 | MP0008875_abnormal_xenobiotic_pharmacok | 1.39252876 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 1.38715926 |
| 78 | MP0008569_lethality_at_weaning | 1.36684987 |
| 79 | MP0003252_abnormal_bile_duct | 1.35630615 |
| 80 | MP0000716_abnormal_immune_system | 1.33922721 |
| 81 | MP0003303_peritoneal_inflammation | 1.33068176 |
| 82 | MP0010234_abnormal_vibrissa_follicle | 1.31045545 |
| 83 | MP0004742_abnormal_vestibular_system | 1.30823811 |
| 84 | MP0001440_abnormal_grooming_behavior | 1.30381336 |
| 85 | MP0005551_abnormal_eye_electrophysiolog | 1.28080687 |
| 86 | MP0003300_gastrointestinal_ulcer | 1.28005763 |
| 87 | MP0008877_abnormal_DNA_methylation | 1.27798257 |
| 88 | MP0003866_abnormal_defecation | 1.26456746 |
| 89 | MP0004947_skin_inflammation | 1.26196717 |
| 90 | MP0004043_abnormal_pH_regulation | 1.26016557 |
| 91 | MP0003724_increased_susceptibility_to | 1.24635149 |
| 92 | MP0002733_abnormal_thermal_nociception | 1.24591070 |
| 93 | MP0002102_abnormal_ear_morphology | 1.23450894 |
| 94 | MP0005409_darkened_coat_color | 1.22220162 |
| 95 | MP0005386_behavior/neurological_phenoty | 1.21564361 |
| 96 | MP0004924_abnormal_behavior | 1.21564361 |
| 97 | MP0002166_altered_tumor_susceptibility | 1.21293314 |
| 98 | MP0002152_abnormal_brain_morphology | 1.21051226 |
| 99 | MP0000689_abnormal_spleen_morphology | 1.19844823 |
| 100 | MP0000955_abnormal_spinal_cord | 1.18756730 |
| 101 | MP0000703_abnormal_thymus_morphology | 1.18143339 |
| 102 | MP0005410_abnormal_fertilization | 1.18111965 |
| 103 | MP0002066_abnormal_motor_capabilities/c | 1.17650921 |
| 104 | MP0001666_abnormal_nutrient_absorption | 1.16410898 |
| 105 | MP0010155_abnormal_intestine_physiology | 1.15157050 |
| 106 | MP0001188_hyperpigmentation | 1.14965584 |
| 107 | MP0002168_other_aberrant_phenotype | 1.14582078 |
| 108 | MP0002118_abnormal_lipid_homeostasis | 1.14445871 |
| 109 | MP0005464_abnormal_platelet_physiology | 1.13610707 |
| 110 | MP0005397_hematopoietic_system_phenotyp | 1.13584716 |
| 111 | MP0001545_abnormal_hematopoietic_system | 1.13584716 |
| 112 | MP0002752_abnormal_somatic_nervous | 1.13104516 |
| 113 | MP0003879_abnormal_hair_cell | 1.13016773 |
| 114 | MP0003122_maternal_imprinting | 1.11707141 |
| 115 | MP0005187_abnormal_penis_morphology | 1.10963287 |
| 116 | MP0002909_abnormal_adrenal_gland | 1.10592294 |
| 117 | MP0000631_abnormal_neuroendocrine_gland | 1.09483346 |
| 118 | MP0002009_preneoplasia | 1.08741945 |
| 119 | MP0002722_abnormal_immune_system | 1.08286370 |
| 120 | MP0002971_abnormal_brown_adipose | 1.07084050 |
| 121 | MP0002229_neurodegeneration | 1.06665106 |
| 122 | MP0000609_abnormal_liver_physiology | 1.06633222 |
| 123 | MP0001502_abnormal_circadian_rhythm | 1.05634660 |
| 124 | MP0009780_abnormal_chondrocyte_physiolo | 1.04635408 |
| 125 | MP0002653_abnormal_ependyma_morphology | 1.02895981 |
| 126 | MP0000569_abnormal_digit_pigmentation | 1.02849357 |
| 127 | MP0002405_respiratory_system_inflammati | 1.02657618 |
| 128 | MP0003633_abnormal_nervous_system | 1.01758905 |
| 129 | MP0008961_abnormal_basal_metabolism | 0.99708569 |
| 130 | MP0002429_abnormal_blood_cell | 0.99209601 |
| 131 | MP0001661_extended_life_span | 0.99062661 |
| 132 | MP0003690_abnormal_glial_cell | 0.98186275 |
| 133 | MP0009278_abnormal_bone_marrow | 0.97673065 |
| 134 | MP0005171_absent_coat_pigmentation | 0.97033343 |
| 135 | MP0001963_abnormal_hearing_physiology | 0.96714968 |
| 136 | MP0001765_abnormal_ion_homeostasis | 0.95334888 |
| 137 | MP0002933_joint_inflammation | 0.95082525 |
| 138 | MP0008469_abnormal_protein_level | 0.94926190 |
| 139 | MP0001845_abnormal_inflammatory_respons | 0.94866367 |
| 140 | MP0002233_abnormal_nose_morphology | 0.94300154 |
| 141 | MP0005375_adipose_tissue_phenotype | 0.94169409 |
| 142 | MP0004145_abnormal_muscle_electrophysio | 0.94069687 |
| 143 | MP0000015_abnormal_ear_pigmentation | 0.92844516 |
| 144 | MP0002693_abnormal_pancreas_physiology | 0.91894574 |
| 145 | MP0005448_abnormal_energy_balance | 0.91790449 |
| 146 | MP0008874_decreased_physiological_sensi | 0.91298430 |
| 147 | MP0005666_abnormal_adipose_tissue | 0.89375956 |
| 148 | MP0002970_abnormal_white_adipose | 0.88063962 |
| 149 | MP0004885_abnormal_endolymph | 0.87974156 |
| 150 | MP0009785_altered_susceptibility_to | 0.87474321 |
| 151 | MP0001542_abnormal_bone_strength | 0.87360534 |
| 152 | MP0000372_irregular_coat_pigmentation | 0.86982158 |
| 153 | MP0001905_abnormal_dopamine_level | 0.85911900 |
| 154 | MP0003121_genomic_imprinting | 0.85545653 |
| 155 | MP0003878_abnormal_ear_physiology | 0.85030369 |
| 156 | MP0005377_hearing/vestibular/ear_phenot | 0.85030369 |
| 157 | MP0009333_abnormal_splenocyte_physiolog | 0.84718994 |
| 158 | MP0003631_nervous_system_phenotype | 0.83807924 |
| 159 | MP0002078_abnormal_glucose_homeostasis | 0.81899641 |
| 160 | MP0005334_abnormal_fat_pad | 0.81624094 |
| 161 | MP0003861_abnormal_nervous_system | 0.81617632 |
| 162 | MP0005623_abnormal_meninges_morphology | 0.81466565 |
| 163 | MP0004142_abnormal_muscle_tone | 0.81016503 |
| 164 | MP0004808_abnormal_hematopoietic_stem | 0.80892876 |
| 165 | MP0008872_abnormal_physiological_respon | 0.79630765 |
| 166 | MP0004085_abnormal_heartbeat | 0.79598523 |
| 167 | MP0002928_abnormal_bile_duct | 0.78494023 |
| 168 | MP0001348_abnormal_lacrimal_gland | 0.78258648 |
| 169 | MP0001851_eye_inflammation | 0.78032559 |
| 170 | MP0002136_abnormal_kidney_physiology | 0.76184285 |
| 171 | MP0000003_abnormal_adipose_tissue | 0.75057990 |
| 172 | MP0003634_abnormal_glial_cell | 0.74886111 |
| 173 | MP0002069_abnormal_eating/drinking_beha | 0.74668081 |
| 174 | MP0000751_myopathy | 0.74241500 |
| 175 | MP0000026_abnormal_inner_ear | 0.71458095 |
| 176 | MP0005389_reproductive_system_phenotype | 0.70668651 |
| 177 | MP0000013_abnormal_adipose_tissue | 0.70654196 |
| 178 | MP0004134_abnormal_chest_morphology | 0.69229786 |
| 179 | MP0003329_amyloid_beta_deposits | 0.68146375 |
| 180 | MP0002751_abnormal_autonomic_nervous | 0.67474152 |
| 181 | MP0003137_abnormal_impulse_conducting | 0.66370167 |
| 182 | MP0004484_altered_response_of | 0.65418342 |
| 183 | MP0002876_abnormal_thyroid_physiology | 0.64480737 |
| 184 | MP0001529_abnormal_vocalization | 0.63531691 |
| 185 | MP0003698_abnormal_male_reproductive | 0.61986267 |
| 186 | MP0001943_abnormal_respiration | 0.59244051 |
| 187 | MP0001177_atelectasis | 0.59201678 |
| 188 | MP0005535_abnormal_body_temperature | 0.55994765 |
| 189 | MP0010770_preweaning_lethality | 0.52444976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Febrile seizures (HP:0002373) | 5.83051725 |
| 2 | Atonic seizures (HP:0010819) | 5.63517554 |
| 3 | Focal motor seizures (HP:0011153) | 5.50066247 |
| 4 | Focal seizures (HP:0007359) | 5.14149821 |
| 5 | Optic neuritis (HP:0100653) | 4.81856296 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.81856296 |
| 7 | Myositis (HP:0100614) | 4.39253448 |
| 8 | Orchitis (HP:0100796) | 4.32366340 |
| 9 | Myokymia (HP:0002411) | 4.30009002 |
| 10 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.20241991 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.10871594 |
| 12 | Absence seizures (HP:0002121) | 4.08999995 |
| 13 | Pancreatic fibrosis (HP:0100732) | 3.86753149 |
| 14 | Generalized tonic-clonic seizures (HP:0002069) | 3.76006014 |
| 15 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.69725583 |
| 16 | Gait imbalance (HP:0002141) | 3.64857303 |
| 17 | Abnormality of the fingertips (HP:0001211) | 3.62827707 |
| 18 | Epileptic encephalopathy (HP:0200134) | 3.62603425 |
| 19 | Dialeptic seizures (HP:0011146) | 3.57733663 |
| 20 | Panhypogammaglobulinemia (HP:0003139) | 3.54539113 |
| 21 | Visual hallucinations (HP:0002367) | 3.49519163 |
| 22 | Hyperventilation (HP:0002883) | 3.46868664 |
| 23 | Congenital primary aphakia (HP:0007707) | 3.41679921 |
| 24 | Progressive cerebellar ataxia (HP:0002073) | 3.33995036 |
| 25 | Nephrogenic diabetes insipidus (HP:0009806) | 3.30998285 |
| 26 | Hypothermia (HP:0002045) | 3.23166520 |
| 27 | Keratoconjunctivitis sicca (HP:0001097) | 3.22610728 |
| 28 | Medial flaring of the eyebrow (HP:0010747) | 3.20630034 |
| 29 | Abnormal ciliary motility (HP:0012262) | 3.20312880 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.12778340 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.12778340 |
| 32 | Colitis (HP:0002583) | 3.11952033 |
| 33 | Anosmia (HP:0000458) | 3.10450870 |
| 34 | Limb dystonia (HP:0002451) | 3.10259274 |
| 35 | Keratoconjunctivitis (HP:0001096) | 3.03466067 |
| 36 | Molar tooth sign on MRI (HP:0002419) | 3.02617154 |
| 37 | Abnormality of midbrain morphology (HP:0002418) | 3.02617154 |
| 38 | Hypoplastic ischia (HP:0003175) | 3.02096068 |
| 39 | Encephalitis (HP:0002383) | 2.98163838 |
| 40 | Rhinitis (HP:0012384) | 2.97075305 |
| 41 | Recurrent fungal infections (HP:0002841) | 2.96193818 |
| 42 | Eczematoid dermatitis (HP:0000976) | 2.93685650 |
| 43 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.88681317 |
| 44 | Abnormality of macular pigmentation (HP:0008002) | 2.88355377 |
| 45 | Action tremor (HP:0002345) | 2.85124844 |
| 46 | Genital tract atresia (HP:0001827) | 2.84138746 |
| 47 | Hyperlipoproteinemia (HP:0010980) | 2.83145951 |
| 48 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.82493625 |
| 49 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.82493625 |
| 50 | Prolonged bleeding time (HP:0003010) | 2.82400456 |
| 51 | Deep venous thrombosis (HP:0002625) | 2.81853251 |
| 52 | Truncal ataxia (HP:0002078) | 2.79643518 |
| 53 | Meningitis (HP:0001287) | 2.79119687 |
| 54 | Broad-based gait (HP:0002136) | 2.77996586 |
| 55 | Absent/shortened dynein arms (HP:0200106) | 2.74799959 |
| 56 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.74799959 |
| 57 | Ankle clonus (HP:0011448) | 2.73123382 |
| 58 | Inflammation of the large intestine (HP:0002037) | 2.69698264 |
| 59 | Hemoptysis (HP:0002105) | 2.67329314 |
| 60 | Gaze-evoked nystagmus (HP:0000640) | 2.65070667 |
| 61 | Pulmonary embolism (HP:0002204) | 2.63180951 |
| 62 | Gastrointestinal inflammation (HP:0004386) | 2.61497766 |
| 63 | Poor coordination (HP:0002370) | 2.58069547 |
| 64 | Vaginal atresia (HP:0000148) | 2.54523522 |
| 65 | Vasculitis (HP:0002633) | 2.54093390 |
| 66 | Dyschromatopsia (HP:0007641) | 2.53922126 |
| 67 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.52241698 |
| 68 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.51965087 |
| 69 | Gastrointestinal infarctions (HP:0005244) | 2.51017695 |
| 70 | Decreased central vision (HP:0007663) | 2.49348781 |
| 71 | Retinal dysplasia (HP:0007973) | 2.48328219 |
| 72 | Papilledema (HP:0001085) | 2.47075941 |
| 73 | Abnormality of the ischium (HP:0003174) | 2.44874226 |
| 74 | Spontaneous hematomas (HP:0007420) | 2.43415514 |
| 75 | Genetic anticipation (HP:0003743) | 2.40273170 |
| 76 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.38346174 |
| 77 | Hypochromic anemia (HP:0001931) | 2.37674145 |
| 78 | Postaxial hand polydactyly (HP:0001162) | 2.35859398 |
| 79 | Median cleft lip (HP:0000161) | 2.35380656 |
| 80 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.34990583 |
| 81 | Supranuclear gaze palsy (HP:0000605) | 2.34343046 |
| 82 | Pulmonary infiltrates (HP:0002113) | 2.31715514 |
| 83 | Arterial thrombosis (HP:0004420) | 2.30550889 |
| 84 | Protruding tongue (HP:0010808) | 2.30491261 |
| 85 | Prominent nose (HP:0000448) | 2.29083573 |
| 86 | Generalized hypopigmentation of hair (HP:0011358) | 2.28759866 |
| 87 | Bradycardia (HP:0001662) | 2.27477455 |
| 88 | Agammaglobulinemia (HP:0004432) | 2.27020255 |
| 89 | Recurrent skin infections (HP:0001581) | 2.26500563 |
| 90 | Truncal obesity (HP:0001956) | 2.26464472 |
| 91 | Dysdiadochokinesis (HP:0002075) | 2.26384791 |
| 92 | Failure to thrive in infancy (HP:0001531) | 2.26098776 |
| 93 | Hemorrhage of the eye (HP:0011885) | 2.24897769 |
| 94 | Specific learning disability (HP:0001328) | 2.24205958 |
| 95 | Obstructive sleep apnea (HP:0002870) | 2.23697616 |
| 96 | Increased IgE level (HP:0003212) | 2.22702753 |
| 97 | Joint hemorrhage (HP:0005261) | 2.22540956 |
| 98 | Complement deficiency (HP:0004431) | 2.22190360 |
| 99 | Insomnia (HP:0100785) | 2.21618162 |
| 100 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.20516466 |
| 101 | Impaired smooth pursuit (HP:0007772) | 2.19776709 |
| 102 | Central scotoma (HP:0000603) | 2.18527759 |
| 103 | Nephronophthisis (HP:0000090) | 2.17977066 |
| 104 | Torticollis (HP:0000473) | 2.17713508 |
| 105 | Fair hair (HP:0002286) | 2.16807749 |
| 106 | Postaxial foot polydactyly (HP:0001830) | 2.14484627 |
| 107 | Abnormality of the lower motor neuron (HP:0002366) | 2.12038297 |
| 108 | Chronic hepatic failure (HP:0100626) | 2.10325090 |
| 109 | Depression (HP:0000716) | 2.10277259 |
| 110 | Abnormality of pain sensation (HP:0010832) | 2.09350576 |
| 111 | Impaired pain sensation (HP:0007328) | 2.09350576 |
| 112 | Severe visual impairment (HP:0001141) | 2.09038452 |
| 113 | Blue irides (HP:0000635) | 2.07251211 |
| 114 | True hermaphroditism (HP:0010459) | 2.06907148 |
| 115 | Pustule (HP:0200039) | 2.05361016 |
| 116 | Abnormality of dentin (HP:0010299) | 2.04625541 |
| 117 | Syncope (HP:0001279) | 2.03575155 |
| 118 | Abnormal EKG (HP:0003115) | 2.03520908 |
| 119 | Keratitis (HP:0000491) | 2.02793310 |
| 120 | Abnormality of T cell physiology (HP:0011840) | 2.02458425 |
| 121 | Poor eye contact (HP:0000817) | 2.01822990 |
| 122 | Heterotopia (HP:0002282) | 2.01803443 |
| 123 | Drooling (HP:0002307) | 2.01608843 |
| 124 | Excessive salivation (HP:0003781) | 2.01608843 |
| 125 | Gingival bleeding (HP:0000225) | 2.00820930 |
| 126 | Amblyopia (HP:0000646) | 2.00781156 |
| 127 | Gangrene (HP:0100758) | 2.00611933 |
| 128 | Epistaxis (HP:0000421) | 2.00593814 |
| 129 | Postural instability (HP:0002172) | 2.00465961 |
| 130 | Fetal akinesia sequence (HP:0001989) | 2.00432842 |
| 131 | Abnormality of the endocardium (HP:0004306) | 1.99298248 |
| 132 | Abnormality of the periventricular white matter (HP:0002518) | 1.98904105 |
| 133 | Acne (HP:0001061) | 1.96878900 |
| 134 | Recurrent bacterial skin infections (HP:0005406) | 1.95958709 |
| 135 | Recurrent viral infections (HP:0004429) | 1.95363320 |
| 136 | Inappropriate behavior (HP:0000719) | 1.94348285 |
| 137 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.94077724 |
| 138 | Gingivitis (HP:0000230) | 1.93832019 |
| 139 | Hypoplasia of the thymus (HP:0000778) | 1.92755362 |
| 140 | Prolonged partial thromboplastin time (HP:0003645) | 1.91793405 |
| 141 | Anorexia (HP:0002039) | 1.91154671 |
| 142 | Dysmetria (HP:0001310) | 1.90225069 |
| 143 | Recurrent abscess formation (HP:0002722) | 1.90197112 |
| 144 | Slow saccadic eye movements (HP:0000514) | 1.89542964 |
| 145 | Palpitations (HP:0001962) | 1.89302964 |
| 146 | Absent speech (HP:0001344) | 1.89290862 |
| 147 | Hyperkalemia (HP:0002153) | 1.88480640 |
| 148 | Insidious onset (HP:0003587) | 1.87678625 |
| 149 | Termporal pattern (HP:0011008) | 1.87678625 |
| 150 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.86525945 |
| 151 | Abnormality of T cells (HP:0002843) | 1.86285831 |
| 152 | Intellectual disability, moderate (HP:0002342) | 1.86052963 |
| 153 | Chronic bronchitis (HP:0004469) | 1.85897039 |
| 154 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.85225454 |
| 155 | Dysmetric saccades (HP:0000641) | 1.84632169 |
| 156 | Abnormality of salivation (HP:0100755) | 1.84621017 |
| 157 | Choroideremia (HP:0001139) | 1.83600168 |
| 158 | Recurrent sinusitis (HP:0011108) | 1.83278414 |
| 159 | Impaired social interactions (HP:0000735) | 1.82386522 |
| 160 | Abnormal social behavior (HP:0012433) | 1.82386522 |
| 161 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.81754984 |
| 162 | Left ventricular hypertrophy (HP:0001712) | 1.81209605 |
| 163 | Abnormal eating behavior (HP:0100738) | 1.80817287 |
| 164 | Agitation (HP:0000713) | 1.80467223 |
| 165 | Abnormality of the corticospinal tract (HP:0002492) | 1.79946728 |
| 166 | Nasal polyposis (HP:0100582) | 1.79912785 |
| 167 | Neoplasm of the heart (HP:0100544) | 1.78906497 |
| 168 | Anxiety (HP:0000739) | 1.78873098 |
| 169 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.78846007 |
| 170 | Prolonged QT interval (HP:0001657) | 1.77612346 |
| 171 | Recurrent bronchitis (HP:0002837) | 1.77382275 |
| 172 | Scanning speech (HP:0002168) | 1.76572069 |
| 173 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.75980599 |
| 174 | Focal dystonia (HP:0004373) | 1.75287093 |
| 175 | Abnormality of lateral ventricle (HP:0030047) | 1.74921288 |
| 176 | Decreased circulating renin level (HP:0003351) | 1.74707085 |
| 177 | Abnormality of the pleura (HP:0002103) | 1.74471023 |
| 178 | Neonatal hypoglycemia (HP:0001998) | 1.73515503 |
| 179 | Clumsiness (HP:0002312) | 1.70773765 |
| 180 | Hypochromic microcytic anemia (HP:0004840) | 1.68965261 |
| 181 | Abnormality of complement system (HP:0005339) | 1.67832307 |
| 182 | Poikilocytosis (HP:0004447) | 1.66698166 |
| 183 | Chronic diarrhea (HP:0002028) | 1.66239174 |
| 184 | Widely spaced teeth (HP:0000687) | 1.65572546 |
| 185 | Stomatitis (HP:0010280) | 1.64924271 |
| 186 | Menorrhagia (HP:0000132) | 1.62170899 |
| 187 | Cheilitis (HP:0100825) | 1.61511942 |
| 188 | T lymphocytopenia (HP:0005403) | 1.58150571 |
| 189 | Abnormal drinking behavior (HP:0030082) | 1.57506445 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.14758427 |
| 2 | NTRK3 | 3.13899866 |
| 3 | MAP2K7 | 3.12466459 |
| 4 | ERBB3 | 3.00806945 |
| 5 | MAP3K4 | 2.81839532 |
| 6 | CASK | 2.70243362 |
| 7 | DAPK2 | 2.66614748 |
| 8 | ARAF | 2.64839937 |
| 9 | FRK | 2.62822134 |
| 10 | CDK12 | 2.44463392 |
| 11 | MARK1 | 2.44317457 |
| 12 | TRIB3 | 2.42074493 |
| 13 | NTRK2 | 2.37355627 |
| 14 | MINK1 | 2.29118314 |
| 15 | ERN1 | 2.27282854 |
| 16 | MAPK13 | 2.23861388 |
| 17 | RIPK1 | 2.14771311 |
| 18 | BMPR2 | 2.13728555 |
| 19 | MAP4K1 | 2.12000044 |
| 20 | EPHA4 | 2.08784934 |
| 21 | NEK9 | 2.00428082 |
| 22 | PLK2 | 1.98086808 |
| 23 | TAOK3 | 1.94828789 |
| 24 | FGFR4 | 1.93540533 |
| 25 | EEF2K | 1.82209520 |
| 26 | FGFR3 | 1.80855378 |
| 27 | MAP2K4 | 1.79041712 |
| 28 | TYK2 | 1.75882470 |
| 29 | SIK2 | 1.74190368 |
| 30 | PRPF4B | 1.73382068 |
| 31 | BLK | 1.68260267 |
| 32 | AKT3 | 1.60514294 |
| 33 | MAP3K12 | 1.55584125 |
| 34 | BRD4 | 1.54392867 |
| 35 | MAP3K7 | 1.49351172 |
| 36 | BTK | 1.45772519 |
| 37 | SIK1 | 1.43643653 |
| 38 | DAPK1 | 1.41314917 |
| 39 | JAK1 | 1.41076308 |
| 40 | NLK | 1.40985643 |
| 41 | EPHA3 | 1.39826849 |
| 42 | EPHB1 | 1.39127307 |
| 43 | MAP2K3 | 1.38646588 |
| 44 | SGK2 | 1.33301466 |
| 45 | PAK6 | 1.33083277 |
| 46 | UHMK1 | 1.31967000 |
| 47 | SYK | 1.30156182 |
| 48 | TNK2 | 1.29460363 |
| 49 | BRAF | 1.28858579 |
| 50 | CAMKK1 | 1.26711100 |
| 51 | CDK5 | 1.25421685 |
| 52 | TXK | 1.24078098 |
| 53 | SGK494 | 1.23461911 |
| 54 | SGK223 | 1.23461911 |
| 55 | PHKG1 | 1.22038207 |
| 56 | PHKG2 | 1.22038207 |
| 57 | PRKCG | 1.21528945 |
| 58 | MAPK15 | 1.18064862 |
| 59 | TNIK | 1.16882820 |
| 60 | ZAP70 | 1.16451211 |
| 61 | ITK | 1.15176978 |
| 62 | JAK3 | 1.15151401 |
| 63 | CAMKK2 | 1.13695240 |
| 64 | MAPKAPK3 | 1.11323824 |
| 65 | FGFR2 | 1.08538761 |
| 66 | PLK4 | 1.08514223 |
| 67 | GRK5 | 1.08261028 |
| 68 | PKN2 | 1.07892097 |
| 69 | CAMK1D | 1.06376874 |
| 70 | STK38 | 1.05078321 |
| 71 | MAP3K13 | 1.04627498 |
| 72 | KSR2 | 1.04404947 |
| 73 | CDK19 | 1.03945640 |
| 74 | SGK3 | 1.02689006 |
| 75 | MAPK11 | 0.98919548 |
| 76 | PRKD3 | 0.98845979 |
| 77 | NTRK1 | 0.97661589 |
| 78 | CSNK1G2 | 0.96937334 |
| 79 | WNK4 | 0.96917335 |
| 80 | PRKAA2 | 0.96776202 |
| 81 | CAMK2B | 0.95596247 |
| 82 | MAP2K6 | 0.95032947 |
| 83 | TEC | 0.94006174 |
| 84 | HCK | 0.91989059 |
| 85 | BMPR1B | 0.91129132 |
| 86 | PAK3 | 0.90923430 |
| 87 | MAP3K14 | 0.90464581 |
| 88 | CSF1R | 0.89219247 |
| 89 | ACVR1B | 0.89090820 |
| 90 | SRPK1 | 0.88929913 |
| 91 | DYRK1A | 0.87987156 |
| 92 | JAK2 | 0.87390507 |
| 93 | SIK3 | 0.87384344 |
| 94 | MAPK12 | 0.86946364 |
| 95 | RET | 0.85435870 |
| 96 | PRKCH | 0.85175691 |
| 97 | KSR1 | 0.84936239 |
| 98 | LCK | 0.84270759 |
| 99 | TRPM7 | 0.82950420 |
| 100 | RPS6KA2 | 0.82279816 |
| 101 | CSK | 0.82238421 |
| 102 | CAMK2D | 0.81817316 |
| 103 | MAPKAPK5 | 0.80392757 |
| 104 | PIK3CG | 0.79501149 |
| 105 | GRK6 | 0.77166462 |
| 106 | CAMK1G | 0.75663220 |
| 107 | OXSR1 | 0.74369967 |
| 108 | KIT | 0.74301353 |
| 109 | MTOR | 0.74141309 |
| 110 | TYRO3 | 0.73967146 |
| 111 | MELK | 0.73895964 |
| 112 | CAMK2A | 0.72995360 |
| 113 | YES1 | 0.71403463 |
| 114 | CDK18 | 0.69211894 |
| 115 | CDK15 | 0.66501366 |
| 116 | IKBKE | 0.65249219 |
| 117 | IRAK4 | 0.65116173 |
| 118 | INSRR | 0.64914361 |
| 119 | PNCK | 0.64781840 |
| 120 | PIK3CA | 0.64327279 |
| 121 | MAPK7 | 0.62072366 |
| 122 | CSNK1A1L | 0.61701707 |
| 123 | CCNB1 | 0.61349947 |
| 124 | STK11 | 0.61266053 |
| 125 | PRKAA1 | 0.60676528 |
| 126 | CDK14 | 0.58573862 |
| 127 | CAMK2G | 0.58211425 |
| 128 | PDPK1 | 0.58199723 |
| 129 | LYN | 0.56812580 |
| 130 | CDK11A | 0.56224028 |
| 131 | CSNK1G3 | 0.55786571 |
| 132 | RIPK4 | 0.55735546 |
| 133 | PDK1 | 0.54444299 |
| 134 | PRKCQ | 0.53264362 |
| 135 | MARK3 | 0.51173600 |
| 136 | RPS6KB1 | 0.50358547 |
| 137 | PRKD2 | 0.49911204 |
| 138 | CAMK4 | 0.49885636 |
| 139 | CAMK1 | 0.49838434 |
| 140 | MAP2K2 | 0.49349165 |
| 141 | FES | 0.47919701 |
| 142 | PRKCE | 0.47662996 |
| 143 | PRKCZ | 0.46912026 |
| 144 | MARK2 | 0.46855745 |
| 145 | MAP3K6 | 0.46202010 |
| 146 | HIPK2 | 0.46200469 |
| 147 | FER | 0.45964035 |
| 148 | SGK1 | 0.43018645 |
| 149 | GRK1 | 0.41385035 |
| 150 | PTK2B | 0.40899741 |
| 151 | DDR2 | 0.40264368 |
| 152 | MAP3K2 | 0.40260212 |
| 153 | MAPK10 | 0.39156317 |
| 154 | FGR | 0.39013398 |
| 155 | ICK | 0.38510885 |
| 156 | PINK1 | 0.38351215 |
| 157 | PRKCB | 0.37433293 |
| 158 | RAF1 | 0.36928844 |
| 159 | WNK1 | 0.36572030 |
| 160 | MAPK8 | 0.36018911 |
| 161 | MAP3K1 | 0.34861620 |
| 162 | CDC42BPA | 0.34177761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 5.73210847 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.27521650 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.02226611 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.77982976 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.77347098 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.71548919 |
| 7 | Phototransduction_Homo sapiens_hsa04744 | 2.65007762 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.56687536 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.50098356 |
| 10 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.31047569 |
| 11 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.26452122 |
| 12 | ABC transporters_Homo sapiens_hsa02010 | 2.22955145 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.16601191 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 2.14751256 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 2.07684993 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 2.03198434 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.96235887 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.87177457 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.81942971 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.74901407 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.72252857 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.71561239 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.71248832 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.64428670 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.60958783 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.58730259 |
| 27 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.56108222 |
| 28 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.55141790 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.47687818 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.46868201 |
| 31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.45332459 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42564977 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.40434768 |
| 34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.40404180 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.36316957 |
| 36 | Renin secretion_Homo sapiens_hsa04924 | 1.36033545 |
| 37 | Lysine degradation_Homo sapiens_hsa00310 | 1.34597217 |
| 38 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.32698906 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32571053 |
| 40 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.26745687 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25567959 |
| 42 | Insulin resistance_Homo sapiens_hsa04931 | 1.24564975 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.24494345 |
| 44 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.21386530 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21101172 |
| 46 | Cocaine addiction_Homo sapiens_hsa05030 | 1.18500342 |
| 47 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.15422214 |
| 48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.15223671 |
| 49 | Long-term depression_Homo sapiens_hsa04730 | 1.11194456 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11183780 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.10404505 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.08496873 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06868704 |
| 54 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.04734451 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 1.03958134 |
| 56 | Histidine metabolism_Homo sapiens_hsa00340 | 1.03623824 |
| 57 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.02450533 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.02245149 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.01031330 |
| 60 | Gap junction_Homo sapiens_hsa04540 | 1.00750122 |
| 61 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99095565 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.96907501 |
| 63 | Axon guidance_Homo sapiens_hsa04360 | 0.96503351 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95497154 |
| 65 | Retinol metabolism_Homo sapiens_hsa00830 | 0.95341341 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.94891365 |
| 67 | Alcoholism_Homo sapiens_hsa05034 | 0.91692788 |
| 68 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.90877388 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90444131 |
| 70 | Melanogenesis_Homo sapiens_hsa04916 | 0.89665968 |
| 71 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87464253 |
| 72 | Measles_Homo sapiens_hsa05162 | 0.86113112 |
| 73 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.85611841 |
| 74 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85352480 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85301756 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.84990190 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.82842335 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82829154 |
| 79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.82550373 |
| 80 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.81267345 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80969140 |
| 82 | Allograft rejection_Homo sapiens_hsa05330 | 0.80415178 |
| 83 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80018218 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79358809 |
| 85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78833193 |
| 86 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.77597424 |
| 87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77583149 |
| 88 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.75821476 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.75683123 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.75530444 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74653815 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73991326 |
| 93 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73125456 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71600643 |
| 95 | Influenza A_Homo sapiens_hsa05164 | 0.71383033 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71260365 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70479238 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69371684 |
| 99 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69351494 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67073070 |
| 101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65645328 |
| 102 | Tuberculosis_Homo sapiens_hsa05152 | 0.64270066 |
| 103 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.64222085 |
| 104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64116127 |
| 105 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64111812 |
| 106 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63723034 |
| 107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.63513428 |
| 108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61408878 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61286734 |
| 110 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.61230229 |
| 111 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.60820507 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60781477 |
| 113 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60156324 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60038543 |
| 115 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59914979 |
| 116 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.59698883 |
| 117 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59490256 |
| 118 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.59047847 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56980954 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56011926 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55531519 |
| 122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55252066 |
| 123 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54348271 |
| 124 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.53454165 |
| 125 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53173707 |
| 126 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52325135 |
| 127 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48078137 |
| 128 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.47468115 |
| 129 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46447201 |
| 130 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45352557 |
| 131 | Bile secretion_Homo sapiens_hsa04976 | 0.44910460 |
| 132 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44562136 |
| 133 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43109426 |
| 134 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.42631463 |
| 135 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41449791 |
| 136 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38752006 |
| 137 | Prion diseases_Homo sapiens_hsa05020 | 0.38507749 |
| 138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37921875 |
| 139 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36953284 |
| 140 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.36683959 |
| 141 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34846116 |
| 142 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33334423 |
| 143 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33260268 |
| 144 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32642214 |
| 145 | Tight junction_Homo sapiens_hsa04530 | 0.31514202 |
| 146 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.29676579 |
| 147 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29645449 |
| 148 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.25846267 |
| 149 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24984328 |
| 150 | Endocytosis_Homo sapiens_hsa04144 | 0.24158841 |
| 151 | Hepatitis C_Homo sapiens_hsa05160 | 0.22184503 |
| 152 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.19571015 |
| 153 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19175455 |
| 154 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.18678917 |
| 155 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.17291739 |
| 156 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.16503441 |
| 157 | Alzheimers disease_Homo sapiens_hsa05010 | 0.16174079 |
| 158 | Phagosome_Homo sapiens_hsa04145 | 0.14859823 |

